MOZ-TIF2, but not BCR-ABL, confers properties of leukemic stem cells to committed murine hematopoietic progenitorsBrian J.P. Huntly, D. Gary Gilliland, R. M. Rowan et al.|Cancer Cell|2004Cited by 701
PKC412 overcomes resistance to imatinib in a murine model of FIP1L1-PDGFRα-induced myeloproliferative diseaseJan Cools, D. Gary Gilliland, Elizabeth H. Stover et al.|Cancer Cell|2003Cited by 218
MOZ-TIF2, but Not BCR-ABL, Confers Properties of Leukemic Stem Cells to Committed Murine Hematopoietic Progenitors.Brian J.P. Huntly, Gary Gilliland, Hirokazu Shigematzu et al.|Blood|2004Cited by 5